Please login to the form below

Not currently logged in
Email:
Password:

Dr Robert Kim joins Apellis as chief medical officer

Brings experience from Novartis, Genentech and GSK

Apellis Pharmaceuticals Dr Robert KimDr Robert Kim has taken up a role at Apellis Pharmaceuticals as chief medical officer, bringing to the US clinical stage immunotherapy company experience from Novartis, Genentech and GSK.

While at Genentech he managed the Lucentis phase III clinical programme through to its first approval in wet age related macular degeneration.

Meanwhile, at he served at GSK as VP of clinical ophthalmology, helping build its early stage clinical pipeline, and was VP and head of pharmaceutical product development at Novartis/Alcon.

Most recently he was at retina startup Vision Medicines, where he was chief medical officer and head of R&D.

In his new role at Louisville, Kentucky-based Apellis Dr Kim will help the company optimise its drug development strategy as its clinical programmes progress toward late-stage clinical testing.

Apellis CEO Cedric Francois said: "Bob is an experienced clinical drug developer whose deep knowledge and experience will help us prepare for our confirmatory trials in geography atrophy and the further expansion of our exciting clinical pipeline centred on the inhibition of complement factor C3."

11th August 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics